As interest in alternative mental health care continues growing, this Better U Ketamine eligibility report examines the brand-stated screening process, licensed-provider evaluation, guided at-home program, and temporary federal telemedicine rules prospective patients should verify before beginning the assessment.
LOS ANGELES, CA / ACCESS Newswire / August 5, 2026 / You saw an ad for Better U - maybe scrolling Facebook, maybe a friend going through something similar mentioned it - and "at-home ketamine therapy" caught your attention enough to bring you here. Before anything else: this is a paid advertorial, a commission may be earned through qualifying links in this article, and product claims belong to the brand, not this publication. Quick facts to know going in: Better U is an at-home, prescription ketamine program for depression, anxiety, and PTSD; ketamine is FDA-approved as an anesthetic, not for psychiatric conditions, so this use is off-label; and the company behind the ads isn't the one that actually treats you - separate, independently licensed Medical Groups handle your evaluation and prescription. Official site: betterucare.com. Details here reflect brand materials reviewed in August 2026.
Better U Ketamine Consumer Research 2026: Researching Who the At-Home Ketamine Program Is Designed For and What Happens Before Approval
TL;DR: Getting into Better U's ketamine program comes down to one thing: a licensed clinician's individual evaluation, not the online assessment you fill out first - and there are 10 specific conditions where the brand's own safety materials say clinicians generally won't prescribe. That evaluation runs through three separate entities - a non-clinical platform, an independently licensed Medical Group, and an independent pharmacy - and depends on a temporary federal rule set to expire December 31, 2026, that currently lets doctors prescribe controlled substances by telemedicine without an in-person exam. This piece breaks down who actually qualifies, what the screening checks for, and what happens if that federal deadline passes before you enroll. Chasing pricing, refund terms, or patient reviews instead? this separate release has that.
→ Start Better U's free eligibility assessment
The Three Entities Behind Every Better U Prescription
This part might sound like fine print, but it's actually the thing worth paying attention to first: for a controlled substance, "three separate licensed organizations are involved" is a good sign, not a red flag. A site that just ships you a prescription with no licensed medical group in the picture is the one to worry about. The brand you see in the ads isn't actually the one that treats you - that's split across three separate organizations, according to Better U's own Terms of Service:
Better U, Inc. - runs the website, the intake platform, the companion app, and billing. Its own Terms state plainly that it does not provide medical or clinical services, does not practice medicine, and does not create a doctor-patient relationship. It is a technology and administrative layer, not a prescriber.
Independently licensed Medical Groups - the clinicians who actually evaluate patients and write prescriptions. Better U's current Terms name several affiliated groups, including Better U Clinical, P.A., Better U Clinical CA, ZF Medical New York, PC, and Better Now Clinical NJ, PC. Which one treats you depends on your state.
Independent, licensed pharmacies - fill and ship the prescribed medication. Per the Terms, prescriptions default to Better U's partner network - pharmacies the brand says meet its quality, sterile-compounding, and shipping standards - unless a patient requests a different, appropriately licensed pharmacy authorized to dispense the prescribed medication and meet any applicable compounding requirements.
Better U's published Terms describe this three-part structure - administrative platform, independently operated Medical Groups, and licensed pharmacies - as the architecture behind every prescription. What it means practically: a question about your evaluation is a Medical Group matter, not Better U, Inc.'s. A question about your medication is a pharmacy matter. Better U's Terms state that Better U, Inc. does not provide clinical services and disclaims responsibility for the acts or omissions of the independent healthcare providers and pharmacies in its network, subject to applicable law - not that the company can never be held responsible for anything under any circumstance. Because your health information moves between these three entities, it's also worth knowing that patient privacy for the clinical pieces of this process is governed by HIPAA as a published privacy framework - not a marketing claim this article is making on Better U's behalf, but the actual federal law that applies to your medical records regardless of which entity is holding them at a given moment.
Buyer Takeaway: Before you enroll, know which of the three entities you'd actually be dealing with for a given problem - a billing question goes to Better U, Inc.; a clinical question goes to your state's Medical Group; a shipping or medication question goes to the pharmacy.
Who Better U's Telehealth Program Is Built For
According to the brand's own materials, Better U positions its at-home ketamine program for adults dealing with depression, anxiety, PTSD, or chronic stress - specifically people who've already tried standard antidepressants or talk therapy without the relief they were hoping for. Better U-affiliated clinicians may consider ketamine therapy for conditions including treatment-resistant depression, PTSD, and certain anxiety disorders, the brand's Important Safety Information page explains, based on an individual clinical evaluation rather than a fixed checklist. The brand is explicit that this determination belongs to a licensed clinician, not to the marketing page, the online assessment, or a patient's own read of their symptoms.
The brand offers two primary entry points, though this article is not covering package pricing - this separate piece on Better U's cost structure and refund terms covers that ground in full:
Introduction track - positioned by the brand for challenges that are more recent, within roughly the last 12 months.
Transformation track - positioned for longer-standing, more chronic difficulty.
The program is explicitly not positioned as a crisis or emergency service, the brand's own safety materials make clear. If you're in a mental health emergency, including suicidal thoughts, the brand's own Terms direct you to call 911, go to the nearest emergency room, or contact a crisis line - including the 988 Suicide & Crisis Lifeline - rather than use the platform.
Buyer Takeaway: The audience description above is a marketing profile, not an eligibility guarantee. The exclusion list further down this article is what actually determines whether a clinician will treat you - read that before assuming you're a fit.
→ See if you're a fit for Better U
How Does Better U's Enrollment and Screening Process Work?
A Better U enrollment moves through a fairly specific sequence before any medication ships, according to the brand's own process description on its Important Safety Information page:
Free online assessment. A short intake screens for basic eligibility and risk factors before anything clinical happens.
Care coordinator contact. Per the brand, a care coordinator follows up to confirm medical history and walk through basic safety information - this happens before the clinical evaluation, not instead of it.
Virtual clinical evaluation. Described on Better U's Important Safety Information page as 30 to 55 minutes depending on the provider and patient, conducted by a licensed clinician affiliated with the Medical Group covering your state. The clinician reviews medical and psychiatric history, current medications, lifestyle, and goals, and determines - independently - whether ketamine is clinically appropriate. (A separate treatment-preparation appointment, described below, runs on its own shorter timeline and shouldn't be confused with this evaluation.)
Treatment-preparation session. A separate appointment with a Certified Integration Guide to prepare for dosing mechanics, expectations, and the Peer Supporter requirement (below) before any session happens.
At-home dosing sessions, using a blood-pressure cuff supplied in the brand's "Brain Box" starter kit, logged in the companion app before each session per the brand's protocol.
Recurring clinician check-ins, described by the brand as typically monthly, to review progress, side effects, and any needed adjustment to the plan.
This isn't a one-time approval, the brand's own safety page notes - a clinician can pause or stop treatment at any point in the sequence if the ongoing risk-benefit picture changes, and no specific outcome is promised at any step.
Buyer Takeaway: The assessment you fill out first is a screen, not an approval. Care-coordination review and a licensed clinical evaluation still stand between that form and an actual prescription.
→ Take Better U's free assessment
Who Qualifies for Better U's Ketamine Program? 10 Disqualifying Conditions, Explained
This is the part of the process the ads don't spend much time on, and it's arguably the most useful thing to check before you invest twenty minutes in the intake form. Better U's eligibility requirements aren't published as a single checklist anywhere on the brand's marketing pages - they're spread across its Important Safety Information page, which states plainly that affiliated clinicians generally do not prescribe at-home ketamine to people who fall into these 10 categories:
Anyone younger than 18
Those who are pregnant or nursing
Those with acute, active substance dependence
Anyone with a psychotic disorder, or a history of unaddressed psychotic symptoms
Bipolar disorder involving severe mania
Unstable cardiovascular disease, uncontrolled high blood pressure, significant vascular disease, serious respiratory illness, or certain seizure disorders
A history of intracerebral hemorrhage, or significantly elevated intracranial or intraocular pressure
Moderate to severe liver disease, or significant kidney disease
Known hypersensitivity to ketamine or esketamine
Anyone who does not meet the clinical threshold for a psychiatric diagnosis consistent with accepted standards of care
These criteria are applied alongside state and federal requirements and evolving practice guidelines, the brand's own materials note, including those referenced from the American Psychiatric Association. In some cases, a clinician may request medical clearance or records from a patient's primary-care or specialty provider before proceeding, and a hybrid model - starting in-office before transitioning to at-home protocols - may be recommended for patients whose initial dosing warrants closer monitoring, where such in-office support is available.
The public Terms reviewed for this article don't clearly spell out what refund, credit, or fee treatment applies specifically when a clinician declines to prescribe after payment - that's a distinct scenario from the general cancellation language the Terms do cover. Confirm this in writing before you pay; the fuller refund-terms discussion lives in this separate piece on Better U's pricing and refund policy.
Buyer Takeaway: If any item on this list applies to you, ask the care-coordination team directly, before paying, whether it's an automatic disqualifier or something a clinician would weigh case by case - the brand's materials frame most of these as generally-not-recommended rather than absolute, but the final call sits with the evaluating clinician.
→ Check Better U's full eligibility list
The Peer Supporter Requirement
Better U's own Important Safety Information page states that at-home ketamine has additional safety considerations because a clinician is not physically present during dosing. The brand's required mitigation is a "Peer Supporter," and it works one of two ways:
In-person: an adult present during dosing sessions to help maintain a safe environment. Per the brand, Peer Supporters are asked to review educational material and confirm they understand their role before a patient begins dosing.
Virtual, when available: per Better U's own safety page, if in-person support isn't available, a virtual peer-support option with a trained team member may be available during sessions for an additional fee. Whether virtual support is offered for your specific plan, and whether a separate charge applies, is worth confirming directly rather than assuming - the brand describes it as conditional, not universally available.
Buyer Takeaway: If you don't have a reliable adult available for dosing sessions, ask before you pay whether the virtual peer-support alternative is actually offered for your plan and whether a separate charge applies - don't assume it's automatically included.
The Brain Box: What Better U's At-Home Monitoring Kit Includes
Patients approved for treatment receive a kit the brand calls the "Brain Box," according to its own product pages. It includes:
A blood-pressure cuff for at-home monitoring
A meditation mask
"Heart diffraction" or "heart glasses," used during sessions
A journal and pen for integration work
Printed app instructions
The prescribed medication itself ships separately through the fulfillment pharmacy. The blood-pressure cuff exists specifically because ketamine can raise blood pressure, the brand's Important Safety Information page explains - patients are instructed to log a reading in the companion app before starting each session, under clinical guidance.
The kit is included in the package price rather than sold separately, per the brand's own pages. Exact contents are described consistently across the brand's own package listings, though packaging details can be updated by the brand over time without a corresponding update to older marketing pages - worth a quick confirmation if a specific item matters to you.
Buyer Takeaway: The blood-pressure cuff isn't a wellness add-on. Per the brand's own materials, it's one component of the at-home monitoring protocol, and it doesn't replace clinical supervision - skipping the pre-session check undercuts the safety measure the brand built around it.
The Hybrid Model: When In-Office Care Precedes At-Home Dosing
Some patients may be recommended a hybrid model that combines in-office and at-home care rather than going straight to self-administered dosing, per Better U's own Important Safety Information page. Under this approach, a patient may begin treatment in an office setting so a clinician can monitor initial dosing more closely, then transition to at-home protocols if and when the clinical team determines it's appropriate based on patient-reported outcomes and safety information. Where available, the brand states patients may be referred to local clinics or partner sites for this additional in-person support.
This option is described by the brand as location- and clinician-dependent, not something every patient can request on demand. If closer initial monitoring appeals to you - particularly if any item on the exclusion-criteria list above gives you pause - asking about hybrid availability in your area is a reasonable question to raise during the clinical evaluation rather than assuming it isn't offered.
Buyer Takeaway: A hybrid start doesn't mean you're a lesser candidate - per the brand's own framing, it's a clinical judgment about how closely your initial dosing should be monitored, not a mark against your eligibility.
Is Ketamine FDA-Approved? What "Off-Label" Means for Better U Patients
Ketamine is a real, FDA-approved medication - as an anesthetic, administered by injection in clinical settings. It is not FDA-approved for depression, anxiety, PTSD, or any other psychiatric condition. Using it for those purposes is considered off-label, Better U's own Important Safety Information page explains, meaning the FDA has not evaluated or determined that ketamine is safe and effective for psychiatric use, nor established a standard, safe dose for that purpose.
Off-label prescribing of an FDA-approved drug is legal when a licensed prescriber does it using independent clinical judgment, and it's routine across medicine broadly - it isn't unique to Better U or to ketamine. What makes it worth flagging here specifically is the combination: an off-label psychiatric use, of a Schedule III controlled substance, dispensed for at-home self-administration without a clinician physically present. That combination is exactly what the next two sections cover.
A related, FDA-approved product exists for comparison: esketamine (brand name Spravato), a nasal spray chemically related to ketamine, which does carry FDA approval for treatment-resistant depression and for depressive symptoms in adults with major depressive disorder who have acute suicidal ideation or behavior. Spravato may be available in-office in select states, Better U's own safety page notes, administered under its FDA-required Risk Evaluation and Mitigation Strategy (REMS) program - a different regulatory framework from the compounded at-home ketamine prescribed through Better U-affiliated clinicians. If nasal-spray eligibility interests you specifically, confirm current availability and cost directly with Better U's clinical team rather than assuming it's an option everywhere the brand advertises.
Buyer Takeaway: "Off-label" doesn't mean unregulated or illegal - it means a licensed prescriber is applying independent clinical judgment to an FDA-approved drug outside its approved indication. It does mean the FDA hasn't evaluated ketamine's safety or dosing for psychiatric use the way it has for esketamine under REMS.
→ See how Better U's evaluation works
The DEA Telemedicine Rule That Makes At-Home Ketamine Prescribing Possible
This is the single most important piece of regulatory context for anyone considering an at-home controlled-substance prescription, and it's worth spelling out precisely because it has an expiration date.
Ketamine's legal status: a Schedule III controlled substance under federal law.
The baseline rule: the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 normally requires at least one in-person medical evaluation before a controlled substance can be prescribed through telemedicine.
Since the COVID-19 public health emergency: the DEA and HHS have repeatedly issued temporary rules suspending that in-person requirement for Schedule II-V controlled substances prescribed via real-time telemedicine.
The current rule: a fourth temporary extension, published on December 31, 2025, running January 1 through December 31, 2026.
What it authorizes: a DEA-registered practitioner may prescribe Schedule II-V controlled substances via telemedicine without a prior in-person medical evaluation, provided all other conditions in the rule are met.
Per the Federal Register's official notice, that's the specific legal basis. A permanent framework has not replaced this temporary approach. A prior proposed rule from January 2025 would have created special telemedicine registrations for practitioners and platforms, but that proposal has not been finalized as of this article's review. What that means in plain terms: an appropriately DEA-registered and state-licensed Better U clinician may be able to prescribe ketamine after a virtual evaluation alone, without an in-person exam, because of this specific, dated federal flexibility - not because ketamine telemedicine is permanently exempt from the in-person requirement. Confirm directly with Better U's care team, and independently through DEA.gov, that the applicable flexibility is still in effect at the time you're considering enrollment, particularly if you're reading this well after December 2026.
Buyer Takeaway: The at-home model depends on a rule that's already been extended four times and could be replaced with a permanent (and possibly different) framework, or allowed to lapse. No further extension should be assumed unless the DEA and HHS actually announce one - neither Better U's marketing nor this article can settle that in advance.
What Happens If the DEA Flexibility Isn't Extended Again
This is a fair question to ask before committing to a multi-session program, and it's one the brand's marketing materials don't address directly. If the temporary telemedicine flexibility for controlled substances lapses without a replacement, the practical effect - based on how the underlying Ryan Haight framework works - would be a return to the in-person evaluation requirement for new patients seeking a Schedule III prescription via telemedicine. Patients already established in an ongoing clinician relationship are generally treated differently under DEA guidance than brand-new patients, though the exact transition rules would depend on whatever final regulation, if any, replaces the current temporary extension.
Practically, this means: if you're reading this article close to or after December 31, 2026, it's worth confirming with Better U's care team - and independently, directly with DEA.gov or a current legal source - whether the flexibility that makes remote, no-in-person-exam prescribing possible is still active, has been replaced by a permanent rule with different conditions, or has lapsed. This is a genuinely live regulatory question, not a settled one, and no single article - including this one - can promise it will still be true by the time you read it.
Buyer Takeaway: If your enrollment timeline runs close to a calendar-year boundary, build in a buffer to re-check the DEA's rule status. No further extension should be assumed unless DEA and HHS actually announce one.
The FDA's Compounded Ketamine Warning, Explained
Separately from the DEA's telemedicine rule, the FDA has issued direct warnings specifically about compounded ketamine products used for psychiatric purposes. On October 10, 2023, the FDA warned patients and health care providers about potential risks associated with compounded ketamine products - including oral and sublingual formulations - for treating psychiatric disorders. This followed an earlier, narrower February 2022 alert focused on compounded ketamine nasal spray.
The FDA's warning lists the agency's core concerns:
Ketamine is not FDA-approved for any psychiatric disorder
Compounded drugs generally, including compounded ketamine, are not FDA-approved products and haven't been evaluated by the FDA for safety, effectiveness, or quality before reaching patients
Using compounded ketamine without monitoring by a health care provider - for things like sedation, dissociation, and changes in blood pressure or heart rate - may put patients at risk for serious adverse events
The FDA also stated it isn't aware of evidence that compounded ketamine is safer, more effective, or faster-acting than medications the agency has actually approved for these psychiatric conditions.
This warning applies specifically to the category outside REMS-level supervision - the framework that governs the FDA-approved Spravato nasal spray, but not the compounded at-home ketamine Better U prescribes. Better U describes screening, blood-pressure monitoring, the Peer Supporter requirement, and monthly clinician check-ins as components of its at-home protocol, covered in the sections above. The public materials reviewed for this article don't establish that these measures were created specifically in response to the FDA's October 2023 communication - the safeguards are real and brand-documented, but the FDA warning and Better U's protocol are two separately sourced facts, not a stated cause-and-effect the brand has confirmed.
Buyer Takeaway: The FDA's warning isn't a statement about Better U specifically - it's about the entire category of compounded, at-home ketamine for psychiatric use. Whether Better U's specific mitigations (screening, monitoring kit, Peer Supporter, check-ins) adequately address the FDA's stated concerns is a clinical judgment call, not something this article - or the brand's own marketing - can settle for you.
→ Get the details on Better U's screening
Better U Ketamine Risks and Side Effects Disclosed by the Brand
Ketamine can cause a range of side effects, some of which may be serious, according to Better U's own Important Safety Information page. The brand's disclosed risks include:
Dissociation, altered perception, or confusion
Drowsiness, dizziness, impaired coordination, or difficulty thinking clearly
Nausea, vomiting, or increased salivation
Increased blood pressure and heart rate
Headache or blurred vision
Anxiety, agitation, or other changes in mood
Worsening of depression or anxiety, or new or worsening suicidal thoughts or behavior
Urinary and bladder symptoms (urgency, pain, frequency, or difficulty urinating)
Potential for misuse, abuse, and dependence in some individuals
The brand also discloses a set of more serious, less common adverse events: significant elevations in blood pressure that may raise stroke or cardiovascular risk, respiratory depression that could be life-threatening, severe confusion or dangerous changes in behavior or judgment, worsening of underlying psychiatric conditions such as new or worsening psychosis or mania, and severe bladder or urinary tract problems with potential long-term complications from repeated high-dose use. Patients experiencing difficulty breathing, chest pain, severe confusion, loss of consciousness, urinary problems, or thoughts of harming themselves or others should seek emergency medical help immediately, the brand states - call 911 or go to the nearest emergency room.
Better U's materials also address impairment directly. The brand instructs patients to:
Not drive, operate heavy machinery, swim, climb, or engage in other potentially hazardous activities for at least the remainder of the day after a dose, or longer if effects persist, unless a clinician explicitly clears them
Avoid major legal, financial, or relationship decisions while under the influence of ketamine or immediately afterward
Buyer Takeaway: This list comes directly from Better U's own safety disclosures, not from an independent clinical review by this article. Read it against your own health history and ask your evaluating clinician direct questions about anything on it before your first dose.
Is Better U Right for You? A Two-Sided Look
Better U's model is built around adults who have already tried standard antidepressants or talk therapy without the relief they hoped for, who are comfortable with a largely self-directed, technology-based treatment model, and who can either arrange an in-person Peer Supporter or use the brand's virtual peer-support alternative - that's the brand's own eligibility framing. None of that is a guarantee of approval - it's the profile the brand says it's designed around.
On the other side, the exclusion criteria above are broader than a lot of at-home telehealth marketing implies, and the brand is explicit that a clinician's independent judgment governs every case. If you have any condition on that list, or you're uncertain how it would be weighed, a preliminary step is asking Better U's care-coordination team before you complete a full paid enrollment - that conversation can typically be requested before purchase.
Whether the ketamine-specific research base (real, and discussed at the mechanism level in published psychiatric literature) actually translates into your outcome is, again, a question for a licensed clinician after an individualized evaluation.
Buyer Takeaway: The exclusion criteria are one part of the clinician's individualized eligibility assessment, not the whole picture - but checking your own history against that list before you enroll is still the single most useful thing you can do with the information in this article.
→ Find out where you stand with Better U
Things to Verify Before You Start the Assessment
None of the items below are accusations - they're facts this article couldn't fully confirm from public materials alone, or that depend on details specific to you and your state. Each is worth a direct question to Better U's care team before you invest time in a full enrollment.
Which Medical Group covers your state. The specific licensed entity that evaluates and prescribes for you depends on where you live. Better U's current Terms name several affiliated groups; ask directly which one is responsible for your state rather than assuming.
Whether the DEA telemedicine flexibility is still active. The current federal rule runs through December 31, 2026. If you're reading this after that date, confirm directly with Better U and independently via DEA.gov that a current extension or permanent rule is in place before assuming remote-only prescribing is still available.
Whether a Peer Supporter is required for your specific plan, and whether any separate charge applies for the virtual alternative. The brand describes in-person support as generally required, with a virtual option when available - confirm your specific situation before enrolling.
Current nasal-spray (Spravato) eligibility, if that delivery method interests you. It's a separate, FDA-approved product available in-office in select states under REMS requirements - distinct from Better U's core at-home program - and eligibility criteria should be confirmed directly rather than assumed.
Which pharmacy would fill your prescription, and what switching involves. Per the brand's Terms, prescriptions default to a partner-pharmacy network unless you request an appropriately licensed alternative capable of any required compounding.
Whether a hybrid (in-office then at-home) model is available in your area. The brand describes this as an option for some patients whose initial dosing benefits from closer in-person monitoring - availability depends on location and clinician recommendation.
Is Better U Available in My State?
Not everywhere. Better U's own site lists a specific set of states where remote services are currently available, and that list has shown minor variation across different pages on the brand's own site during this article's research. Hybrid and in-office options are more limited still, available in only select locations. Service availability changes over time - confirm it using Better U's current state-specific pages or directly with the company rather than relying on any single page, including this one.
Buyer Takeaway: State availability is one of the fastest things to rule in or out. Check it before you spend time on the full assessment, not after.
→ See current eligibility details
Fast Facts
Program type: At-home, prescription ketamine telehealth for depression, anxiety, PTSD, and chronic stress
Platform entity: Better U, Inc. (non-clinical administrative platform; does not prescribe)
Prescribing entity: Independently licensed Medical Group, varies by state (includes Better U Clinical, P.A.; Better U Clinical CA; ZF Medical New York, PC; Better Now Clinical NJ, PC)
Dispensing entity: Independent partner pharmacy network; alternate pharmacies permitted if appropriately licensed
FDA status of ketamine for psychiatric use: Off-label; ketamine is FDA-approved only as an anesthetic
Comparable FDA-approved product: Esketamine (Spravato) nasal spray, available in-office in select states under REMS
Federal telemedicine basis: DEA/HHS Fourth Temporary Extension of COVID-19 telemedicine flexibilities, in effect through December 31, 2026
Underlying federal law: Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (in-person exam requirement, currently suspended by the temporary extension)
Relevant FDA safety communication: October 10, 2023 warning on compounded ketamine products for psychiatric use (preceded by a narrower February 2022 nasal-spray alert)
Enrollment sequence: online assessment → care-coordinator call → 30-55 minute clinical evaluation → treatment-preparation session → at-home dosing → monthly clinician check-ins
Required safety measure: In-person "Peer Supporter" during dosing, or a conditional virtual peer-support alternative
Monitoring tool: Blood-pressure cuff supplied in the brand's "Brain Box" kit, logged before each session
Minimum age: 18
Hybrid care option: In-office initial dosing with transition to at-home protocols, where available
Crisis services: Not offered; brand directs emergencies to 911, the nearest ER, or the 988 Suicide & Crisis Lifeline
Pricing, refund terms, and patient review data: Not covered in this article - see separate coverage
Buyer Takeaway: Nearly every entry above traces back to either Better U's own published Terms and safety pages or a primary federal source - a useful sign the underlying structure is real, even before you get to whether it's the right fit clinically.
Quick Answers
Is Better U's ketamine prescribing FDA-approved? Ketamine itself is FDA-approved only as an anesthetic. Its use for depression, anxiety, or PTSD through Better U's program is off-label, meaning the FDA has not evaluated or approved ketamine for these psychiatric uses specifically.
Can Better U prescribe without an in-person exam? Under a temporary federal rule in effect through December 31, 2026, an appropriately DEA-registered and state-licensed clinician may prescribe Schedule III ketamine after a qualifying telemedicine evaluation alone. This is not a permanent exemption - confirm current status directly if reading this after that date.
Who actually decides if I'm eligible? A licensed clinician affiliated with your state's Medical Group, after an individual evaluation - not the online assessment, not Better U, Inc. itself, and not this article.
Is a Peer Supporter mandatory? Per the brand's safety materials, yes for at-home dosing, with a virtual peer-support alternative available when offered - confirm whether that alternative applies to your plan and whether it involves an added fee.
→ Check your eligibility with Better U
Frequently Asked Questions
What conditions might Better U's clinicians consider ketamine for?
Per the brand's own materials, affiliated clinicians may consider ketamine therapy for conditions including treatment-resistant depression, PTSD, and certain anxiety disorders, based on an individual clinical evaluation rather than a fixed checklist. The brand does not claim ketamine is appropriate or effective for every patient with these conditions, and a licensed clinician affiliated with your state's Medical Group makes the final determination after reviewing your medical history, psychiatric history, current medications, and stated goals. Patients who don't meet the clinical threshold for a psychiatric diagnosis consistent with accepted standards of care are, per the brand's own safety materials, generally not candidates.
Who actually writes my prescription if I enroll with Better U?
Not Better U, Inc. itself. Prescriptions are written by a licensed clinician employed by one of several independently licensed Medical Groups affiliated with the platform - which specific entity depends on your state. The brand's current Terms name several, including Better U Clinical, P.A., Better U Clinical CA, ZF Medical New York, PC, and Better Now Clinical NJ, PC. Better U, Inc. describes itself in its own Terms of Service as a non-clinical administrative platform that does not practice medicine, does not own or direct the Medical Groups' clinical judgment, and does not itself write, approve, or guarantee any prescription.
What actually happens during the online assessment?
Per the brand's process description, the online assessment is a free, short intake designed to screen for basic eligibility and risk factors before anything clinical happens. It is not a diagnosis and does not itself authorize a prescription. Passing the initial screen leads to a care-coordinator call to confirm medical history, and then to the actual licensed clinical evaluation, where a provider affiliated with your state's Medical Group decides independently whether ketamine therapy is clinically appropriate for you.
How long is the clinical evaluation, and what does the clinician actually review?
Per the brand, the virtual clinical appointment runs 30 to 55 minutes depending on the provider and patient. During that appointment, the clinician reviews your medical and psychiatric history, current medications, lifestyle factors, and treatment goals, answers your questions, and determines whether ketamine therapy is clinically appropriate before any prescription is written. This is the checkpoint where the exclusion criteria discussed above are actually applied to your specific case, not a formality that happens after the decision is already made. Per the brand's own process description, this is also where a clinician may request additional records or medical clearance from a primary-care or specialty provider before proceeding, if your history warrants it.
What is the DEA rule that allows at-home ketamine prescribing without an in-person visit?
Ketamine is a Schedule III controlled substance, and the Ryan Haight Act normally requires an in-person medical evaluation before such a substance can be prescribed via telemedicine. Since the COVID-19 public health emergency, the DEA and HHS have repeatedly issued temporary rules suspending that requirement. The current version - the fourth temporary extension - runs through December 31, 2026, per the Federal Register's official notice, and permits a DEA-registered practitioner to prescribe Schedule II-V controlled substances via telemedicine without a prior in-person exam, provided all other conditions in the rule are met.
Is this DEA flexibility permanent?
No. It is the fourth temporary extension of a flexibility first introduced during the COVID-19 public health emergency, and it currently runs through December 31, 2026. A permanent rule - including a previously proposed framework for special telemedicine registrations - has not been finalized as of this article's review. Confirm current status directly with Better U and independently via DEA.gov if you are reading this close to or after that date. Because the extension has already been renewed four separate times since the COVID-19 public health emergency, a fifth renewal is plausible, but plausibility isn't confirmation - treat the December 31, 2026 date as a real deadline until an official source says otherwise.
What did the FDA say about compounded ketamine specifically?
On October 10, 2023, the FDA warned patients and health care providers about potential risks associated with compounded ketamine products, including oral and sublingual formulations, for treating psychiatric disorders. The agency stated that ketamine is not FDA-approved for any psychiatric disorder, that compounded drugs generally are not FDA-approved and haven't been evaluated by the FDA before reaching patients, and that using compounded ketamine without a health care provider's monitoring may put patients at risk for serious adverse events. This followed an earlier, narrower February 2022 warning focused specifically on compounded ketamine nasal spray.
Is at-home ketamine use riskier than in-clinic use?
Better U's own Important Safety Information page states that at-home ketamine has additional safety considerations compared with in-clinic administration because a clinician isn't physically present during dosing. Better U states it mitigates this with its screening sequence, a required Peer Supporter or virtual alternative, a supplied blood-pressure monitor, and monthly clinician check-ins. Known risks the brand discloses include dissociation, altered perception, increased blood pressure, respiratory depression, and - in some individuals - potential for misuse or dependence. This article does not independently verify safety outcomes beyond what the brand publishes on its own Important Safety Information page.
Does Better U guarantee that ketamine therapy will work for me?
No. The brand's own Terms state that outcomes vary from person to person, as with any medical treatment provided by a licensed professional; no specific symptom relief or functional improvement is promised, and treatment packages don't guarantee success. The Terms separately state that refunds aren't offered based on treatment outcome - the fuller refund discussion, including what that means for your specific package and what happens if you complete a package without the improvement you were hoping for, is covered in the separate Barchart piece on Better U's pricing and refund terms.
Is a Peer Supporter required for every patient?
Per Better U's own safety materials, yes for at-home dosing protocols - an in-person adult is required to be present during sessions to help maintain a safe environment, or a virtual peer-support option is available when offered. If in-person support isn't available, the brand states the virtual option with a trained team member may involve an additional fee - confirm whether it's offered for your plan and whether a separate charge applies before enrolling. Peer Supporters are also asked to review educational materials and confirm they understand their role before dosing sessions begin, which is worth planning for ahead of your treatment-preparation appointment rather than the day of your first session.
What's the difference between Better U's core program and Spravato?
Better U's core at-home program prescribes compounded ketamine off-label for psychiatric use - it does not carry FDA approval for that purpose, and route or formulation specifics should be confirmed with your own prescribing clinician. Spravato (esketamine) is a related but chemically distinct nasal spray with actual FDA approval for treatment-resistant depression and certain acute-suicidal-ideation cases, administered under a Risk Evaluation and Mitigation Strategy (REMS) program in-office. Per the brand, Spravato may be available in select states as a separate, in-office option - confirm current eligibility and location requirements directly rather than assuming it's available everywhere Better U operates.
→ Start your free Better U assessment
Can I switch to a different pharmacy than the one Better U assigns?
Per the brand's Terms, yes - you can request a different, appropriately licensed pharmacy, provided it's authorized to dispense the prescribed medication and meet any applicable compounding requirements, and accepts secure electronic prescriptions or pharmacist-to-pharmacist transfers. Choosing an outside pharmacy may mean paying that pharmacy directly, different shipping timelines outside Better U's stated control, and losing certain in-app medication-tracking features tied to the partner-pharmacy network. The brand's Terms also note that specialized compounding requirements may limit which retail pharmacies are actually able to fulfill the order, so it's worth confirming with your chosen pharmacy directly, before your prescription is routed, that it can handle the specific formulation your clinician prescribes.
Is Better U's telehealth model available in every state?
No - see the state-availability section above for the full picture. Better U's own site lists specific states where remote services are currently available, and that list has shown minor variation across different pages during this article's research. It is not a nationwide service, and hybrid or in-office options are described as more limited still, available in only select locations. Confirm current coverage using Better U's state-specific pages or directly with the company rather than relying on any single source, including this one.
What happens if a clinician decides I'm not a candidate after I've started the process?
A clinician can decline to prescribe at any point if they determine the risks outweigh the potential benefits for a specific patient, regardless of what the initial online assessment suggested - that's according to the brand's own safety materials. The brand states this determination is independent of any administrative or billing process. What happens to any fees already paid in that scenario is a discretionary, case-by-case question under the brand's current Terms - worth asking directly, and in writing, before you pay for a full package.
What if I'm having a mental health emergency while enrolled with Better U?
Better U's own Terms are explicit: its services - including any associated coaching or educational content - are not intended for emergency or crisis situations. If you are experiencing a medical or mental health emergency, including suicidal thoughts or any inability to keep yourself safe, the brand directs you to act immediately: call 911, go to the nearest emergency room, or contact a crisis line, including the 988 Suicide & Crisis Lifeline by call or text, rather than attempting to reach the platform for urgent help.
→ See if Better U is available in your state
Better U Eligibility Verification Checklist
Buyer Takeaway: None of the items below require a paid enrollment to check - every one can be confirmed with a phone call or email to Better U's care-coordination team before you commit.
Confirm which Medical Group entity is licensed to treat patients in your specific state.
Confirm the current status of the DEA telemedicine flexibility if you're enrolling after December 31, 2026.
Review the full exclusion-criteria list on Better U's Important Safety Information page against your own medical and psychiatric history before starting the assessment.
Ask whether a Peer Supporter is required for your specific treatment plan, whether a virtual alternative is available, and whether it involves a separate charge.
Confirm current nasal-spray (Spravato) eligibility criteria directly if that delivery method interests you.
Confirm current state availability, since the brand's service area can change.
Ask what happens - administratively and financially - if your initial clinician determines you're not a candidate after you've paid for a package.
Confirm whether a hybrid in-office-to-at-home model is available in your area, if closer initial monitoring appeals to you.
Save a copy of whichever Important Safety Information and Terms of Service version you're shown at the time you enroll.
The Bottom Line
Strip away the ads and Better U's ketamine eligibility process comes down to a specific regulatory and clinical architecture: a non-clinical platform, an independently licensed Medical Group that actually screens and prescribes, and an independent pharmacy that fills the order, with remote prescribing currently operating under temporary DEA/HHS telemedicine flexibilities, alongside state licensure and other applicable requirements. The brand publishes an online assessment and a detailed list of circumstances in which affiliated clinicians generally do not prescribe at-home ketamine. The off-label framing is disclosed clearly by the brand itself, and the FDA's own warning about compounded, at-home ketamine sits directly alongside the brand's stated mitigations - screening, monitoring, a Peer Supporter, and recurring check-ins.
None of that settles whether it's clinically right for you - that determination belongs to a licensed clinician after an individualized eligibility evaluation. What is within your control: confirm which Medical Group covers your state, read the eligibility criteria against your own history before you start, ask directly about the Peer Supporter requirement and whether any cost applies, and check that the DEA telemedicine flexibility is still active if you're reading this well after this article's review date. Those checks are a preliminary step that takes a few minutes, and they sit alongside the real risks and regulatory dependencies this article has covered.
→ Get started with Better U's assessment
Better U Contact Information
Per Better U's own live contact page as of this article's review:
Phone/text: 323-433-5883
Support email: info@betterucare.com
Support hours: Monday-Friday, 10 a.m.-5 p.m. Pacific (closed national holidays)
General business address (per the brand's Contact Us page): 7060 Hollywood Blvd. #520, Los Angeles, CA 90028
Two address discrepancies are worth flagging rather than silently resolving:
Better U's Terms of Service list a separate DMCA/copyright-notices address (7095 Hollywood Blvd. #422, Los Angeles, CA 90028), distinct from the general Contact Us address above.
The brand information supplied for this article's production listed a third address on West Sunset Blvd. in West Hollywood, which doesn't match either address on the brand's own live pages as of this review.
Which address applies depends on the purpose of your correspondence - confirm by phone before sending anything formal. The phone number, by contrast, is consistent across every source reviewed for this article.
For day-to-day questions about enrollment or eligibility, the brand publishes phone, text, email, and contact-form options.
Disclosure and Compliance Information
Title Reference Notice: The phrase "DEA Deadline" in this article's title refers to this publication's own editorial description of a publicly available federal regulation's expiration date - specifically the DEA and HHS's Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, which runs through December 31, 2026 - and is not an official designation by Better U, the DEA, or any government agency. This publication does not independently substantiate brand marketing claims. Readers seeking verification context should continue reading the sections above.
Material Limitations: This article is based on Better U's own website, Important Safety Information page, Terms of Service (effective date June 3, 2026), live Contact Us page, the Federal Register's official notice on the DEA's fourth temporary telemedicine extension, and independently searched reporting on that extension and on the FDA's October 2023 compounded-ketamine warning, all reviewed through August 2026. This article deliberately does not cover Better U's pricing, refund terms, or patient reviews - those are addressed in a separate Barchart article, linked throughout. No clinical outcomes were independently verified, and no product was independently tested. Where Better U's own materials showed internal inconsistency - for example, differing addresses across its Contact Us page and Terms of Service - this article notes the conflict rather than silently choosing one version. The affiliate link associated with this article could not be directly fetched due to the destination site's automated-access restrictions; readers should independently confirm it resolves correctly before proceeding. Contact the brand directly to verify any material claim before making an enrollment decision.
Compounded Medication Disclosure: Compounded medications, where applicable to a patient's prescription, are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before marketing, in the same manner as an FDA-approved finished drug product.
Prescribing Separation: Prescription medication is available only after independent evaluation and approval by a licensed healthcare provider affiliated with a Medical Group, if clinically appropriate. Approval is not guaranteed, and Better U, Inc. does not itself prescribe or guarantee prescribing outcomes.
Patient Privacy: Handling of patient health information across Better U's platform, the affiliated Medical Groups, and dispensing pharmacies is governed by HIPAA as a published federal privacy framework. This article makes no claim, on Better U's behalf or otherwise, that any specific entity is "HIPAA compliant" - that is a legal determination outside the scope of this coverage. Review the brand's own Notice of Privacy Practices, referenced in its Terms of Service, for specifics.
Third-Party Feedback Platforms: This article does not cover patient review or rating data; where such information is relevant, its accuracy on third-party platforms is not independently endorsed. See the separate Barchart article linked above for that coverage.
Forward-Looking Statements: This article reflects information available as of August 2026. Eligibility criteria, program structure, state availability, and - in particular - the regulatory status of telemedicine controlled-substance prescribing may change after publication. Rely on Better U's official site and direct confirmation from the brand, and on DEA.gov for regulatory status, for current information.
Marketing Language Notice: Attribution language throughout this article identifies statements as brand-stated claims. Any promotional phrases referenced in this article's body are brand-asserted marketing language and do not represent an independent ranking, clinical finding, or lab-verified result.
California Proposition 65: No product-specific California Proposition 65 warning was identified in the Better U materials reviewed for this article. Shipping a prescription medication to California does not, by itself, confirm whether a Proposition 65 warning applies; California buyers with questions should confirm directly with the dispensing pharmacy and their prescribing clinician.
Subscription and Auto-Renewal Notice: Better U's current Terms of Service contain automatic-renewal provisions for some services. This article does not cover package-specific billing terms - confirm whether the ketamine plan you're considering is one-time or recurring, along with cancellation method and notice period, directly with Better U before payment, or see the separate Barchart pricing coverage linked above.
Trademark Acknowledgment: Better U and Spravato are trademarks of their respective owners; no ownership, sponsorship, or affiliation with this publication is implied.
Geographic and Jurisdiction Notice: Availability of Better U's services is limited to specific U.S. states as listed on the brand's official site at the time of this article's review and is subject to change. This article does not address availability outside the United States.
Promotional Content Disclosure: This content is promotional in nature and is intended for consumer education regarding a commercially available telehealth program.
SOURCE: Better U
View the original press release on ACCESS Newswire